C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1186/bcr568.pdf
Reference49 articles.
1. McGuire W: Adjuvant therapy of node-negative breast cancer. N Engl J Med. 1989, 320: 525-527.
2. Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL, Fisher ER, et al: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 1989, 320: 479-489.
3. Fisher B, Redmond C, Dimitrov NV, Bowman D, Legault-Poisson S, Wickerman DL, Wolmark N, Fisher ER, Margolese R, Sutherland C, et al: A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer. N Engl J Med. 1989, 320: 473-478.
4. Allred DC, Clark GM, Tandon AK, Molina R, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff M, Eudey L, McGuire W: HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. J Clin Oncol. 1992, 10: 599-605.
5. Nicholson S, Wright S, Sainsbury JRC, Halcrow P, Kelly P, Angus B, Farndon JR, Harns AL: Epidermal growth factor receptor (EGFR) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failure. J Steroid Biochem. 1990, 27: 811-815.
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer;Cell;2021-01
2. MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer;British Journal of Cancer;2020-01-16
3. Use of Novel Combination Therapies in the Treatment of Advanced HR+/HER2− Breast Cancer;Journal of the National Comprehensive Cancer Network;2018-12
4. Differential cellular responses by oncogenic levels of c-Myc expression in long-term confluent retinal pigment epithelial cells;Molecular and Cellular Biochemistry;2017-11-29
5. High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer;Oncotarget;2017-03-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3